Cargando…
SMARTWOMAN™: Feasibility assessment of a smartphone app to control cardiovascular risk factors in vulnerable diabetic women
BACKGROUND/HYPOTHESIS: SMARTWOMAN™ was designed to develop and assess the feasibility of a smartphone app to control cardiovascular risk factors in vulnerable diabetic women. METHODS: Fourteen African‐American women with diabetes and without known cardiovascular disease were enrolled. A weight‐scale...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712310/ https://www.ncbi.nlm.nih.gov/pubmed/30471130 http://dx.doi.org/10.1002/clc.23124 |
_version_ | 1783446654399021056 |
---|---|
author | Wenger, Nanette K. Williams, Olubunmi O. Parashar, Susmita |
author_facet | Wenger, Nanette K. Williams, Olubunmi O. Parashar, Susmita |
author_sort | Wenger, Nanette K. |
collection | PubMed |
description | BACKGROUND/HYPOTHESIS: SMARTWOMAN™ was designed to develop and assess the feasibility of a smartphone app to control cardiovascular risk factors in vulnerable diabetic women. METHODS: Fourteen African‐American women with diabetes and without known cardiovascular disease were enrolled. A weight‐scale, glucometer, sphygmomanometer, and FitBit were synchronized to the smartphone, and text messaging was provided. Follow‐up was 6 months. RESULTS: Patients were able to follow instructions for app use and device prompts. Weekly device reporting was 85% for blood glucose, 82.5% for daily steps, and 77% for systolic blood pressure. Patient engagement levels were 85% to 100% at 1 month and 50% to 78% at month 6. The majority reported text messages to be useful, easy to understand, and appropriate in frequency. The women indicated on the exit questionnaire that study participation increased their motivation and ability to take charge of their health. CONCLUSIONS: Use of a smartphone app to control cardiovascular risk factors appears feasible in a population of vulnerable indigent African‐American diabetic women, resulted in increased patient satisfaction and positive reinforcement to healthy behaviors, and warrants a larger clinical outcome trial. |
format | Online Article Text |
id | pubmed-6712310 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wiley Periodicals, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-67123102019-08-28 SMARTWOMAN™: Feasibility assessment of a smartphone app to control cardiovascular risk factors in vulnerable diabetic women Wenger, Nanette K. Williams, Olubunmi O. Parashar, Susmita Clin Cardiol Clinical Investigations BACKGROUND/HYPOTHESIS: SMARTWOMAN™ was designed to develop and assess the feasibility of a smartphone app to control cardiovascular risk factors in vulnerable diabetic women. METHODS: Fourteen African‐American women with diabetes and without known cardiovascular disease were enrolled. A weight‐scale, glucometer, sphygmomanometer, and FitBit were synchronized to the smartphone, and text messaging was provided. Follow‐up was 6 months. RESULTS: Patients were able to follow instructions for app use and device prompts. Weekly device reporting was 85% for blood glucose, 82.5% for daily steps, and 77% for systolic blood pressure. Patient engagement levels were 85% to 100% at 1 month and 50% to 78% at month 6. The majority reported text messages to be useful, easy to understand, and appropriate in frequency. The women indicated on the exit questionnaire that study participation increased their motivation and ability to take charge of their health. CONCLUSIONS: Use of a smartphone app to control cardiovascular risk factors appears feasible in a population of vulnerable indigent African‐American diabetic women, resulted in increased patient satisfaction and positive reinforcement to healthy behaviors, and warrants a larger clinical outcome trial. Wiley Periodicals, Inc. 2019-01-17 /pmc/articles/PMC6712310/ /pubmed/30471130 http://dx.doi.org/10.1002/clc.23124 Text en © 2018 The Authors. Clinical Cardiology published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Investigations Wenger, Nanette K. Williams, Olubunmi O. Parashar, Susmita SMARTWOMAN™: Feasibility assessment of a smartphone app to control cardiovascular risk factors in vulnerable diabetic women |
title | SMARTWOMAN™: Feasibility assessment of a smartphone app to control cardiovascular risk factors in vulnerable diabetic women |
title_full | SMARTWOMAN™: Feasibility assessment of a smartphone app to control cardiovascular risk factors in vulnerable diabetic women |
title_fullStr | SMARTWOMAN™: Feasibility assessment of a smartphone app to control cardiovascular risk factors in vulnerable diabetic women |
title_full_unstemmed | SMARTWOMAN™: Feasibility assessment of a smartphone app to control cardiovascular risk factors in vulnerable diabetic women |
title_short | SMARTWOMAN™: Feasibility assessment of a smartphone app to control cardiovascular risk factors in vulnerable diabetic women |
title_sort | smartwoman™: feasibility assessment of a smartphone app to control cardiovascular risk factors in vulnerable diabetic women |
topic | Clinical Investigations |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712310/ https://www.ncbi.nlm.nih.gov/pubmed/30471130 http://dx.doi.org/10.1002/clc.23124 |
work_keys_str_mv | AT wengernanettek smartwomanfeasibilityassessmentofasmartphoneapptocontrolcardiovascularriskfactorsinvulnerablediabeticwomen AT williamsolubunmio smartwomanfeasibilityassessmentofasmartphoneapptocontrolcardiovascularriskfactorsinvulnerablediabeticwomen AT parasharsusmita smartwomanfeasibilityassessmentofasmartphoneapptocontrolcardiovascularriskfactorsinvulnerablediabeticwomen |